Sukurti naują paskyrą

Užsiregistruokite dabar ir gaukite papildomų naudų:
  • Asmeninės kainos
  • Pristatymo sekimas
  • Iš anksto užpildyta ir greitas atsiskaitymas
  • Užsakymų istorija ir greitas pakartotinis užsakymas
  • Tiksli prekės atsargų būklė
Cart

Jūsų krepšelis tuščias, pridėkite prekių.

Tai puiki proga užpildyti krepšelį kažkuo tikrai ypatingu!

Numatomos siuntimo išlaidos

0,00 €

Iš viso: 0,00 €

image/svg+xml Prisijungti / Registruotis
Prisijunkite arba registruokitės
Prisijungti Sukurti paskyrą
Užsiregistruokite dabar ir gaukite papildomų naudų:
  • Asmeninės kainos
  • Pristatymo sekimas
  • Iš anksto užpildyta ir greitas atsiskaitymas
  • Užsakymų istorija ir greitas pakartotinis užsakymas
  • Tiksli prekės atsargų būklė
1-placeholder

SKU NEV11098

IVISense™ Cat B FAST fluroescent probes enable non-invasive in vivo detection of disease status and progression in oncology, inflammation and other areas associated with Cat B activity.

Associated with tumor aggression, cathepsins are a family of proteases that are pivotal components of signaling pathways that can enhance cancer cell growth and inflammation. Within the human lysosomal cysteine cathepsin family, there are 11 members, including cathepsin B, L, S, and Plasmin. As a family, cysteine cathepsins are involved in the response to anticancer therapy within the tumor microenvironment and play crucial roles in the development of resistance to therapeutics. In particular, cathepsin B expression correlates with the invasive and metastatic capabilities of many tumors, such as in breast cancer where high expression levels of cathepsin B have been linked to highly aggressive tumors. Cathepsin B is also upregulated in a variety of inflammatory cells (including eosinophils, neutrophils, and macrophages).

IVISense Cat B 750 FAST is a Cathepsin B activatable fluorescent probe that is optically silent upon injection and produces fluorescent signal after cleavage by Cathepsin B produced by inflammatory cells and tumor cells. IVISense Cat B 750 FAST may be used to monitor inflammation, tumor activity, progression of disease and the efficacy of therapeutic treatment in applications such as oncology, inflammation, cardiovascular disease and some neurological diseases.

IVISense Cat B 750 FAST™ is a member of a family of activatable fluorescent imaging agents comprising a novel architecture, termed F.A.S.T. (Fluorescent Activatable Sensor Technology) that confers an improved pharmacokinetic profile with a broader range of early imaging time points. This architecture also offers higher target specific signal with reduced background.

For laboratory use only. This product is intended for animal research only and not for use in humans.

Specifikacija

Specifikacija

Neseniai peržiūrėta

Contact

Nova Natura UAB

Kaštonų g. 56, Giraitės k, LT-54310,
Kaunas, Lithuania

nova@novabio.lt
Phone: +370 (620) 70159

Reg No 305063819

Nova Natura OÜ

Valukoja 8, 11415,
Tallinn, Estonia

nova@novabio.ee
Phone: +372 5656 0050

Reg No 14758203

Kontaktai

Naujienlaiškio prenumerata

Prisijunkite prie mūsų naujienlaiškio!
ISO9001 1 e1593687280362